These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29173173)
1. AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate Cancer. Salvi S; Conteduca V; Lolli C; Testoni S; Casadio V; Zaccheroni A; Rossi L; Burgio SL; Menna C; Schepisi G; De Giorgi U Curr Cancer Drug Targets; 2018; 18(9):869-876. PubMed ID: 29173173 [TBL] [Abstract][Full Text] [Related]
2. [ARV-7: A biomarker for the treatment of metastatic castration-resistant prostate cancer]. Chen ZY; Dong Q; Liu LR; Wei Q Zhonghua Nan Ke Xue; 2019 Feb; 25(2):172-176. PubMed ID: 32216207 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Coutinho I; Day TK; Tilley WD; Selth LA Endocr Relat Cancer; 2016 Dec; 23(12):T179-T197. PubMed ID: 27799360 [TBL] [Abstract][Full Text] [Related]
4. Androgen Receptor Rearrangement and Splicing Variants in Resistance to Endocrine Therapies in Prostate Cancer. Ho Y; Dehm SM Endocrinology; 2017 Jun; 158(6):1533-1542. PubMed ID: 28368512 [TBL] [Abstract][Full Text] [Related]
5. ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. Gao S; Ye H; Gerrin S; Wang H; Sharma A; Chen S; Patnaik A; Sowalsky AG; Voznesensky O; Han W; Yu Z; Mostaghel EA; Nelson PS; Taplin ME; Balk SP; Cai C Clin Cancer Res; 2016 Jul; 22(14):3672-82. PubMed ID: 26936914 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
7. Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction. Buelens S; Claeys T; Dhondt B; Poelaert F; Vynck M; Yigit N; Thas O; Ost P; Vandesompele J; Lumen N; Kumps C Clin Genitourin Cancer; 2018 Jun; 16(3):197-205.e5. PubMed ID: 29366632 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns. De Laere B; van Dam PJ; Whitington T; Mayrhofer M; Diaz EH; Van den Eynden G; Vandebroek J; Del-Favero J; Van Laere S; Dirix L; Grönberg H; Lindberg J Eur Urol; 2017 Aug; 72(2):192-200. PubMed ID: 28104311 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor targeting drugs in castration-resistant prostate cancer and mechanisms of resistance. Crona DJ; Milowsky MI; Whang YE Clin Pharmacol Ther; 2015 Dec; 98(6):582-9. PubMed ID: 26331358 [TBL] [Abstract][Full Text] [Related]
10. Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer. Bastos DA; Dzik C; Rathkopf D; Scher HI Oncology (Williston Park); 2014 Aug; 28(8):693-9. PubMed ID: 25140626 [TBL] [Abstract][Full Text] [Related]
11. Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer. Antonarakis ES; Chandhasin C; Osbourne E; Luo J; Sadar MD; Perabo F Oncologist; 2016 Dec; 21(12):1427-1435. PubMed ID: 27628492 [TBL] [Abstract][Full Text] [Related]
12. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer. Martin SK; Kyprianou N Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899 [TBL] [Abstract][Full Text] [Related]
13. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer. Azad AA; Volik SV; Wyatt AW; Haegert A; Le Bihan S; Bell RH; Anderson SA; McConeghy B; Shukin R; Bazov J; Youngren J; Paris P; Thomas G; Small EJ; Wang Y; Gleave ME; Collins CC; Chi KN Clin Cancer Res; 2015 May; 21(10):2315-24. PubMed ID: 25712683 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial. Brighi N; Conteduca V; Gurioli G; Scarpi E; Cursano MC; Bleve S; Lolli C; Schepisi G; Casadei C; Gianni C; Ulivi P; De Giorgi U ESMO Open; 2023 Dec; 8(6):102036. PubMed ID: 37866028 [TBL] [Abstract][Full Text] [Related]
15. AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate. Todenhöfer T; Azad A; Stewart C; Gao J; Eigl BJ; Gleave ME; Joshua AM; Black PC; Chi KN J Urol; 2017 Jan; 197(1):135-142. PubMed ID: 27436429 [TBL] [Abstract][Full Text] [Related]
16. [New generation of androgen receptor antagonist in castration resistant prostate cancer]. Uemura H Nihon Rinsho; 2014 Dec; 72(12):2164-9. PubMed ID: 25518352 [TBL] [Abstract][Full Text] [Related]
17. Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer. Conteduca V; Wetterskog D; Gonzalez-Billalabeitia E; Brighi N; De Giorgi U; Attard G Eur Urol Oncol; 2021 Oct; 4(5):740-744. PubMed ID: 33436326 [TBL] [Abstract][Full Text] [Related]
18. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription. Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis. Li H; Wang Z; Tang K; Zhou H; Liu H; Yan L; Guan W; Chen K; Xu H; Ye Z Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials. Ebrahimi S; Hashemy SI; Sahebkar A; Aghaee Bakhtiari SH Curr Mol Pharmacol; 2021 Oct; 14(4):559-569. PubMed ID: 33357209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]